Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone by Webster LR, Israel RJ

Get full text

The health insurance industry: perpetuating the opioid crisis through policies of cost-containment and profitability by Schatman ME, Webster LR

Get full text

Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain by Webster LR, Israel RJ

Get full text

Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals by Webster LR, Camilleri M, Finn A

Get full text

A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving O... by Webster LR, Hale ME, Yamada T, Wild JE

Get full text

Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain by Peppin JF, Majors K, Webster LR, Simpson DM, Tobias JK, Vanhove GF

Get full text

Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain by Webster LR, Brenner DM, Barrett AC, Paterson C, Bortey E, Forbes WP

Get full text

Open-Label Adhesion Performance Studies of a New Lidocaine Topical System 1.8% versus Lidocaine Patches 5% and Lidocaine Medicated Plaster 5% in Healthy Subjects by Gudin J, Webster LR, Greuber E, Vought K, Patel K, Kuritzky L

Get full text

Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain [Corrigendum] by Webster LR, Brenner DM, Barrett AC, Paterson C, Bortey E, Forbes WP

Get full text